FGFrancis M. Giardiello

Francis M. Giardiello

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Francis M. Giardiello has a total of 73 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Altered neural networks and cognition in a hereditary colon cancer

    by Ryan J. Cali, Benjamin C. Nephew, Constance M. Moore, Serhiy Chumachenko, Ana Cecilia Sala, Beatriz Cintron, Carlos Luciano, Jean A. King, Stephen R. Hooper, Francis M. Giardiello, et al.


  • Open Access

    Altered Resting State Brain Networks and Cognition in Familial Adenomatous Polyposis

    by Ryan J. Cali, Benjamin C. Nephew, Constance M. Moore, Serhiy Chumachenko, Ana Cecilia Sala, Beatriz Cintron, Carlos Luciano, Jean A. King, Stephen R. Hooper, Francis M. Giardiello, et al.

    Familial Adenomatous Polyposis (FAP) is an autosomal dominant disorder caused by mutation of the APC gene presenting with numerous colorectal adenomatous polyps and a near 100% risk of colon cancer. Preliminary research findings from our group indicate that FAP patients experience significant deficits across many cognitive domains. In the current study, fMRI brain metrics in a FAP population and matched controls were used to further the mechanistic understanding of reported cognitive deficits. This research identified and characterized any possible differences in resting brain networks and associations between neural network changes and cognition from 34 participants (18 FAP patients, 16 healthy controls). Functional connectivity analysis was performed using FSL with independent component analysis (ICA) to identify functional networks. Significant differences between cases and controls were observed in 8 well-established resting state networks. With the addition of an aggregate cognitive measure as a covariate, these differences were virtually non-existent, indicating a strong correlation between cognition and brain activity at the network level. The data indicate robust and pervasive effects on functional neural network activity among FAP patients and these effects are likely involved in cognitive deficits associated with this disease.

  • Efficacy and Safety of Curcumin in Treatment of Intestinal Adenomas in Patients With Familial Adenomatous Polyposis

    by Marcia Cruz-Correa, Linda M. Hylind, Jessica Hernandez Marrero, Marianna L. Zahurak, Tracy Murray-Stewart, Robert A. Casero, Elizabeth A. Montgomery, Christine Iacobuzio-Donahue, Lodewijk A. Brosens, G. Johan Offerhaus, et al.


  • Clinical Characteristics of Multiple Colorectal Adenoma Patients Without Germline APC or MYH Mutations

    by Alan H. Tieu, Daniel Edelstein, Jennifer Axilbund, Katharine E. Romans, Lodewijk A. Brosens, Elizabeth Wiley, Linda Bs Hylind, Francis M. Giardiello

    Background: Patients with multiple colorectal adenomas (MCRA) without genetic cause are increasingly being diagnosed. The characteristics and natural history of this condition are not well studied. Materials and Methods: Twenty-seven patients with MCRA, with cumulatively 10 to 99 colorectal adenomas and without deleterious mutations of APC or MYH genes, were investigated. Results of colonoscopies with a mean follow-up of 4.9 years (range, 0 to 27 y) were evaluated. Findings from esophagogastroduodenoscopy and extracolonic manifestations were assessed. Results: The mean age at polyp diagnosis and MCRA diagnosis was 47.8±13.1 years (range, 21 to 72 y) and 50.4±14.6 years (range, 21 to 72 y), respectively. In 22% of patients another family member had MCRA. At first colonoscopy, the mean number of adenomas was 35.0±35.9 (range, 0 to 99). Serrated polyps were rare. Esophagogastroduodenoscopy revealed 47% of patients had upper tract neoplasia. Patients with upper tract findings were diagnosed with MCRA at significantly younger mean age than those without findings, PMUTYH-associated polyposis including surveillance of the upper tract.


  • Risk of thyroid cancer among Caribbean Hispanic patients with familial adenomatous polyposis

    by Nicolás Casellas-Cabrera, Yaritza Díaz-Algorri, Víctor J. Carlo-Chévere, María González-Pons, Natalia Rodríguez-Mañón, Julyann Pérez-Mayoral, Carlos Bertrán-Rodríguez, Marievelisse Soto-Salgado, Francis M. Giardiello, Segundo Rodríguez-Quilichini, et al.

    Familial adenomatous polyposis (FAP) is an inherited form of colorectal cancer characterized by hundreds of adenomatous polyps in the colon and rectum. FAP is also associated with thyroid cancer (TC), but the lifetime risk is still unclear. This study reports the standardized incidence ratio (SIR) of TC in Hispanic FAP patients. TC incidence rates in patients with FAP between the periods of January 1, 2006 to December 31, 2013 were compared with the general population through direct database linkage from the Puerto Rico Central Cancer Registry (PRCCR) and the Puerto Rico Familial Colorectal Cancer Registry (PURIFICAR). The study population consisted of 51 Hispanic patients with FAP and 3239 with TC from the general population. The SIR was calculated using the Indirect Method, defined as observed TC incidence among patients with FAP in PURIFICAR’s cohort (2006–2013) divided by the expected TC incidence based on the PR population rates (2006–2010). SIR values were estimated by sex (male, female, and overall). This study received IRB approval (protocol #A2210207). In Hispanic patients with FAP, the SIR (95 % CI) for TC was 251.73 (51.91–735.65), with higher risk for females 461.18 (55.85–1665.94) than males 131.91 (3.34–734.95). Hispanic FAP patients are at a high risk for TC compared to the general population. Our incidence rates are higher than previous studies, suggesting that this community may be at a higher risk for TC than previously assumed. Implementation of clinical surveillance guidelines and regular ultrasound neck screening in Hispanic FAP patients is recommended.


  • Hereditary Colorectal Cancer

    by Lodewijk A.A. Brosens, G. Johan A. Offerhaus, Francis M. Giardiello


  • Simultaneous juvenile polyposis syndrome and neurofibromatosis type 1

    by Lodewijk A A Brosens, G Johan Offerhaus, Marcia Irene F Canto, Elizabeth A Montgomery, Francis M Giardiello


  • Top Cited Papers

    Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer

    by Francis M. Giardiello, John I. Allen, Jennifer E. Axilbund, C. Richard Boland, Carol A. Burke, Randall W. Burt, James M. Church, Jason A. Dominitz, David A. Johnson, Tonya Kaltenbach, et al.


  • Guidelines on genetic evaluation and management of Lynch syndrome: A consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer

    by Francis M. Giardiello, John I. Allen, Jennifer E. Axilbund, C. Richard Boland, Carol A. Burke, Randall W. Burt, James M. Church, Jason A. Dominitz, David A. Johnson, Tonya Kaltenbach, et al.


  • Serrated polyposis: rapid and relentless development of colorectal neoplasia

    by Daniel L Edelstein, Jennifer E Axilbund, Linda M Hylind, Katharine Romans, Constance A Griffin, Marcia Cruz-Correa, Francis M Giardiello

    Objective Serrated (hyperplastic) polyposis (SP) is a rare disorder with multiple colorectal hyperplastic polyps and often sessile serrated adenomas/polyps (SSA/P) or adenomas. Although associated with colorectal cancer, the course of SP is not well described. Design 44 patients with SP were studied. The results of 146 colonoscopies with median follow-up of 2.0 years (range 0–30) and a median of 1.0 years (range 0.5–6) between surveillance colonoscopies were evaluated. Findings from oesophogastroduodenoscopy examinations were analysed. Results The mean age at diagnosis of SP was 52.5±11.9 years (range 22–78). In two pedigrees (5%) another family member had SP. None of 22 patients had gastroduodenal polyps. All patients had additional colorectal polyps at surveillance colonoscopy. SSA/P or adenomas were found in 25 patients (61%) at first colonoscopy and 83% at last colonoscopy. Recurrent SSA/P or adenomas occurred in 68% of patients at surveillance colonoscopy. Three patients had colorectal cancer. Eleven patients (25%) underwent surgery (mean time from diagnosis of SP 2.0±0.9 years). After surgery all seven surveyed patients developed recurrent polyps in the retained colorectum (4/7 had SSA/P or adenomas). No association was found between colorectal neoplasia and sex, age at diagnosis of SP or initial number of colorectal polyps. Conclusions In SP, rapid and unrelenting colorectal neoplasia development continues in the intact colorectum and retained segment after surgery. These findings support the possibility of annual colonoscopic surveillance, consideration for colectomy when SSA/P or adenomas are encountered and frequent postoperative endoscopic surveillance of the retained colorectum.